Showing results (71-80 of 151) with videos related to
Sort By:
Pageof 16
Annals of Hematology|July 21, 2023
Poor outcome of allogeneic transplantation for therapy-related acute myeloid leukemia induced by prior chemoradiotherapyHiroaki Araie, Yasuyuki Arai, Michiko Kida, et al.Hematological Oncology|March 17, 2022
Outcome of therapy-related myelodysplastic syndrome and oligoblastic acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: A propensity score matched analysisHidehiro Itonaga, Michiko Kida, Atsushi Hamamura, et al.Transplantation and Cellular Therapy|February 19, 2024
Impact of Different Fludarabine Doses in the Fludarabine-Based Conditioning Regimen for Unrelated Bone Marrow TransplantationKodai Kuriyama, Shigeo Fuji, Ayumu Ito, et al.Bone Marrow Transplantation|December 3, 2020
Relapse of acute myeloid leukemia after allogeneic hematopoietic cell transplantation: clinical features and outcomesMasamitsu Yanada, Takaaki Konuma, Satoshi Yamasaki, et al.Bone Marrow Transplantation|January 18, 2022
Disease-specific impact of anti-thymocyte globulin in allogeneic hematopoietic cell transplantation: a nationwide retrospective study on behalf of the JSTCT, transplant complications working groupShigeo Fuji, Tsuneaki Hirakawa, Kuniko Takano, et al.Bone Marrow Transplantation|May 8, 2023
Should a matched sibling donor still be considered the primary option for allogeneic hematopoietic cell transplantation in patients over 50 years of age with myelodysplastic syndrome?Takaaki Konuma, Hidehiro Itonaga, Ken Ishiyama, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 29, 2019
Conditioning Intensity for Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia Patients with Poor-Prognosis Cytogenetics in First Complete RemissionTakaaki Konuma, Tadakazu Kondo, Shohei Mizuno, et al.Transplantation and Cellular Therapy|August 14, 2022
Reducing Mortality of Single-Unit Unrelated Cord Blood Transplantation for Relapsed Acute Myeloid Leukemia after a Previous Allogeneic Transplantation: A Real-World Retrospective Study Over the Past 19 Years in JapanTakaaki Konuma, Shohei Mizuno, Kaito Harada, et al.American Journal of Hematology|January 2, 2024
Association of individual comorbidities with outcomes in allogeneic hematopoietic cell transplantation from unrelated adult donors versus unrelated cord blood: A study on behalf of the Donor/Source and Transplant Complications Working Groups of the Japanese Society for Transplantation and Cellular TherapyTakaaki Konuma, Kaito Harada, Akihito Shinohara, et al.International Journal of Hematology|November 6, 2022
Age and allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemiaMasamitsu Yanada, Satoshi Yamasaki, Takaaki Konuma, et al.Pageof 16